{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:24:18Z","timestamp":1787765058292,"version":"build-2784847793"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although coronary artery aneurysm (CAA) is an uncommon complication of drug-coated balloon (DCB) treatment, the incidence and mechanisms CAA formation after DCB intervention for chronic total occlusion (CTO) remains to be clarified. The aim of this study was to investigate the incidence of CAA after DCB intervention for the treatment of CTO of coronary arteries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>\n                      This was a retrospective analysis of 82 patients, contributing 88 vessels, who underwent successful DCB-only treatment for\n                      <jats:italic>de novo<\/jats:italic>\n                      CTO lesions. Follow-up angiography was performed in all cases, at a mean 208.5 (interquartile range [IQR]: 174.8 to 337.5) days after the index procedure.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CAA was identified in seven vessels, in seven patients, at the site of previous successful DCB-only treatment. Of these, six were fusiform in shape and one saccular, with a mean diameter of 4.2 \u00b1 1.0 mm and length of 6.7 \u00b1 2.6 mm. Six CAAs developed at the CTO inlet site, and all CAAs occurred at the lesions following dissection immediately after DCB treatment. CAAs were not associated with an increased risk of major clinical events over the median follow-up of 676.5 (IQR: 393.8 to 1,304.8) days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The incidence of CAA after DCB-only treatment for CTO lesions was 8.0% in this study. Further research is warranted, using intravascular imaging, to clarify the mechanism of DCB-related CAA formation and prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2022.1039316","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:22:41Z","timestamp":1672820561000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Coronary artery aneurysm formation after paclitaxel-coated balloon-only intervention for de novo coronary chronic total occlusion"],"prefix":"10.3389","volume":"9","author":[{"given":"Eun Jung","family":"Jun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Seok","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitna","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eu-Vin","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong-Mow","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houng Bang","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/s0002-9149(97)00055-6","article-title":"Stress trial investigators. frequency and outcome of development of coronary artery aneurysm after intracoronary stent placement and angioplasty.","volume":"79","author":"Slota","year":"1997","journal-title":"Am J Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/hrt.78.2.136","article-title":"The natural history of aneurysmal coronary artery disease.","volume":"78","author":"Demopoulos","year":"1997","journal-title":"Heart."},{"key":"B3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ccd.1810220203","article-title":"Predictability and prognosis of PTCA-induced coronary artery aneurysms.","volume":"22","author":"Bal","year":"1991","journal-title":"Cathet Cardiovasc Diagn."},{"key":"B4","doi-asserted-by":"publisher","first-page":"487","DOI":"10.4244\/EIJV7I4A79","article-title":"Clinical presentation and outcomes of drug-eluting stent-associated coronary aneurysms.","volume":"7","author":"Hakeem","year":"2011","journal-title":"EuroIntervention."},{"key":"B5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1161\/01.res.86.8.879","article-title":"Arterial paclitaxel distribution and deposition.","volume":"86","author":"Creel","year":"2000","journal-title":"Circ Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/hrt.2006.102244","article-title":"Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries.","volume":"93","author":"Pires","year":"2007","journal-title":"Heart."},{"key":"B7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.4244\/EIJV9I5A97","article-title":"No indication for an unexpected high rate of coronary artery aneurysms after angioplasty with drug-coated balloons.","volume":"9","author":"Kleber","year":"2013","journal-title":"EuroIntervention."},{"key":"B8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1253\/circj.cj-10-0635","article-title":"Clinical outcomes and the risk factors of coronary artery aneurysms that developed after drug-eluting stent implantation.","volume":"75","author":"Kim","year":"2011","journal-title":"Circ J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.5603\/CJ.a2020.0105","article-title":"Provisional drug-coated balloon treatment guided by physiology on de novo coronary lesion.","volume":"28","author":"Shin","year":"2021","journal-title":"Cardiol J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5603\/CJ.a2019.0093","article-title":"Drug-coated balloon treatment in coronary artery disease: recommendations from an asia-pacific consensus group.","volume":"28","author":"Her","year":"2021","journal-title":"Cardiol J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the international DCB consensus group.","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv."},{"key":"B12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0002-9149(91)90780-o","article-title":"Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty.","volume":"68","author":"Huber","year":"1991","journal-title":"Am J Cardiol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0167-5273(89)90062-4","article-title":"Coronary arterial aneurysms after percutaneous transluminal coronary angioplasty \u2014 a not uncommon finding at elective follow-up angiography.","volume":"22","author":"Vassanelli","year":"1989","journal-title":"Int J Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1016\/0735-1097(92)90439-t","article-title":"Relation of deep arterial resection and coronary artery aneurysms after directional coronary atherectomy.","volume":"20","author":"Bell","year":"1992","journal-title":"J Am Coll Cardiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.jacc.2009.01.069","article-title":"Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings.","volume":"53","author":"Alfonso","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.amjcard.2009.08.510","article-title":"Biological effect on coronary restenosis of bare metal stents crimped on paclitaxel coated balloons: preliminary animal data in the porcine overstretch model.","volume":"104","author":"Thim","year":"2009","journal-title":"Am J Cardiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.ehj.2004.06.010","article-title":"Long-term assessment of a novel biodegradable paclitaxel-eluting coronary polylactide stent.","volume":"25","author":"Vogt","year":"2004","journal-title":"Eur Heart J."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1039316\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T07:59:44Z","timestamp":1675151984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.1039316\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":17,"alternative-id":["10.3389\/fcvm.2022.1039316"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.1039316","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"article-number":"1039316"}}